Somatostatin receptor subtype 2 (SSTR2) was found to be increased in adenomas with respect to normal pituitaries while it was decreased in patients non-responding to treatment with long-acting Somatostatin analogues (SSAs) with respect to responders (48) and was involved in GH secretion suppression (75)
Em caso de gestao, lactao ou uso de medicamentos, consulte um profissional de sade antes de usar
Middle East & Africa: Country Analysis 9.3.1
& Lebovitz, H
J Pharmacol Sci 95:1926 Medvidovic-Grubisic M, Stambolija V, Kolenc D, Katancic J, Murselovic T, Plestina-Borjan I, Strbe S, Drmic D, Barisic I, Sindic A, Seiwerth S (2017) Hypermagnesemia disturbances in rats, NO-related: pentadecapeptide BPC 157 abrogates, l-NAME and l-arginine worsen